← Leaderboards
Kayvan R Keshari
Sloan-Kettering Inst Can Research
$12,246,491
Attributed
$17,994,687
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,994,687 · 10
By mechanism
R01$15,912,732 · 6
R00$734,549 · 1
R21$659,720 · 1
S10$600,000 · 1
K99$87,686 · 1
Top collaborators
- Hedvig Hricak12 shared
- Charles H. Cunningham8 shared
- Michael Kharas6 shared
- Taha Merghoub6 shared
- Ronald G Blasberg2 shared
- Moritz Florian Kircher1 shared
- Craig B Thompson1 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Michael Kharas$18,485,709
- Moritz Florian Kircher$4,113,545
- Jiangbin Ye$862,286
Others in their field
Top investigators on “Metabolic”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolicIn VivoImageMalignant NeoplasmsResponseMetabolismTranslatingInnovationDesignBiological MarkersMotivationMonitorMagnetic Resonance ImagingMagnetic ResonanceFutureMetabolic ImagingPyruvateTreatment PlanningGlycolysisCellsTumorNon-Invasive ImagingCancer TherapyMetabolic Abnormality Assessment
Grant awards (41)
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging$711,338
R01 · FY2025 · CA · contact PI
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells$696,769
R01 · FY2025 · CA · contact PI
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy$461,824
R01 · FY2025 · CA
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging$92,576
R01 · FY2025 · CA · contact PI
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging$679,961
R01 · FY2024 · CA · contact PI
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells$668,212
R01 · FY2024 · CA · contact PI
Visualizing oxidative stress using hyperpolarized magnetic resonance$612,929
R01 · FY2024 · CA · contact PI
Development of large-field-of-view hyperpolarized MRI$546,632
R01 · FY2024 · CA · contact PI
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy$438,732
R01 · FY2024 · CA
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging$87,947
R01 · FY2024 · CA · contact PI
Interrogation of the oxidative-stress-induced leukemia program in vivo usingmetabolic imaging$35,552
R01 · FY2024 · CA · contact PI
Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging$728,079
R01 · FY2023 · CA · contact PI
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells$697,232
R01 · FY2023 · CA · contact PI
Visualizing oxidative stress using hyperpolarized magnetic resonance$646,707
R01 · FY2023 · CA · contact PI
Development of large-field-of-view hyperpolarized MRI$571,198
R01 · FY2023 · CA · contact PI
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy$452,588
R01 · FY2023 · CA
Development of large-field-of-view hyperpolarized MRI$29,063
R01 · FY2023 · CA · contact PI
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells$704,431
R01 · FY2022 · CA · contact PI
Visualizing oxidative stress using hyperpolarized magnetic resonance$653,905
R01 · FY2022 · CA · contact PI
Development of large-field-of-view hyperpolarized MRI$637,022
R01 · FY2022 · CA · contact PI
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy$324,453
R01 · FY2022 · CA
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy$296,533
R01 · FY2022 · CA
Development of large-field-of-view hyperpolarized MRI$113,996
R01 · FY2022 · CA · contact PI
Development of large-field-of-view hyperpolarized MRI$778,626
R01 · FY2021 · CA · contact PI
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells$726,151
R01 · FY2021 · CA · contact PI
Visualizing oxidative stress using hyperpolarized magnetic resonance$693,846
R01 · FY2021 · CA · contact PI
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy$633,662
R01 · FY2021 · CA
Development of large-field-of-view hyperpolarized MRI$673,750
R01 · FY2020 · CA · contact PI
Visualizing oxidative stress using hyperpolarized magnetic resonance$656,410
R01 · FY2020 · CA · contact PI
Development of large-field-of-view hyperpolarized MRI$40,276
R01 · FY2020 · CA · contact PI
uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells$209,520
R21 · FY2019 · CA · contact PI
Reproducibility of Hyperpolarized Pyruvate Metabolic Imaging in Prostate Cancer$287,816
R01 · FY2018 · CA · contact PI
uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells$216,000
R21 · FY2018 · CA · contact PI
Reproducibility of Hyperpolarized Pyruvate Metabolic Imaging in Prostate Cancer$287,816
R01 · FY2017 · CA · contact PI
uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells$234,200
R21 · FY2017 · CA · contact PI
Reproducibility of Hyperpolarized Pyruvate Metabolic Imaging in Prostate Cancer$246,700
R01 · FY2016 · CA · contact PI
Human Tissue Culture Bioreactor and Hyperpolarized MR for Biomarker Discovery$244,019
R00 · FY2015 · EB · contact PI
GE Diamond DNP Polarizer$600,000
S10 · FY2014 · OD
Human Tissue Culture Bioreactor and Hyperpolarized MR for Biomarker Discovery$241,530
R00 · FY2014 · EB · contact PI
Human Tissue Culture Bioreactor and Hyperpolarized MR for Biomarker Discovery$249,000
R00 · FY2013 · EB · contact PI
Human Tissue Culture Bioreactor and Hyperpolarized MR for Biomarker Discovery$87,686
K99 · FY2012 · EB · contact PI